INCIDÊNCIA DE ANEMIA E USO DE OMEPRAZOL EM PACIENTES ATENDIDOS EM UM PSF NO MUNICÍPIO DE PARAGUAÇÚ - MG

Abstract

Nutritional anemias are a serious public health problem in the contemporary world, affecting all age groups, including adults and seniors. The impact of anemia and iron deficiency should be evaluated not only by the numerical magnitude in epidemiological terms, but also caused by the clinical implications on the health of affected individuals. Iron is involved in oxygen transport, DNA synthesis and energy metabolism. Anemia may result from several factors, especially the conditions as hemorrhage, genetic abriprmalities, the most common chronic diseases, drug toxicity, especially Omeprazole. Omeprazole is the first medicament to block the final step in the process of secretion hydrochloric acid within the parietal cell. The aim of this study was to know the incidence of anemia in patients taking Omeprazole. In a total of 260 patients seen in the PSF over a period of 13 days, we selected the patients who used Omeprazole, and excluded those who did not use the drug. From those selected, we detected the presence of anemia, according to biochemical tests posted on their record. To analyze anemia, were used biochemical parameters determined by OMS and Mahan. Were found among the 260 patients treated, 68 who attended the inclusion criteria, and among this 68, 24 patients that had some type of change in the blood count. while the remaining 44 patients didn't have the exams altered.